Kewaunee Scientific Co. (NASDAQ:KEQU) Short Interest Up 23.8% in March

Kewaunee Scientific Co. (NASDAQ:KEQU - Get Free Report) was the recipient of a significant increase in short interest during the month of March. As of March 31st, there was short interest totalling 9,900 shares, an increase of 23.8% from the March 15th total of 8,000 shares. Currently, 0.5% of the company's shares are short sold. Based on an average daily volume of 6,500 shares, the short-interest ratio is currently 1.5 days.

Wall Street Analysts Forecast Growth

KEQU has been the subject of several analyst reports. TheStreet lowered shares of Kewaunee Scientific from a "b-" rating to a "c" rating in a research report on Thursday, March 7th. StockNews.com raised shares of Kewaunee Scientific from a "buy" rating to a "strong-buy" rating in a research report on Thursday, March 14th.

Kewaunee Scientific Stock Up 1.9 %

Shares of KEQU stock traded up $0.65 during mid-day trading on Monday, hitting $34.85. 8,349 shares of the stock traded hands, compared to its average volume of 6,584. The stock has a market cap of $99.32 million, a P/E ratio of 11.69 and a beta of 0.69. The stock's fifty day moving average is $31.13 and its two-hundred day moving average is $25.34. Kewaunee Scientific has a 52-week low of $14.56 and a 52-week high of $36.86. The company has a debt-to-equity ratio of 0.61, a current ratio of 2.28 and a quick ratio of 1.76.

Kewaunee Scientific (NASDAQ:KEQU - Get Free Report) last posted its quarterly earnings data on Wednesday, March 6th. The technology company reported $0.85 earnings per share (EPS) for the quarter. Kewaunee Scientific had a net margin of 4.34% and a return on equity of 20.82%. The firm had revenue of $46.78 million for the quarter.

Insider Transactions at Kewaunee Scientific

In other news, VP Elizabeth D. Phillips sold 3,277 shares of the company's stock in a transaction dated Tuesday, March 26th. The shares were sold at an average price of $32.50, for a total value of $106,502.50. Following the transaction, the vice president now directly owns 10,263 shares in the company, valued at $333,547.50. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In related news, VP Douglas J. Batdorff sold 3,500 shares of the company's stock in a transaction dated Friday, March 15th. The shares were sold at an average price of $31.35, for a total value of $109,725.00. Following the completion of the sale, the vice president now directly owns 6,167 shares of the company's stock, valued at $193,335.45. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, VP Elizabeth D. Phillips sold 3,277 shares of the company's stock in a transaction dated Tuesday, March 26th. The stock was sold at an average price of $32.50, for a total transaction of $106,502.50. Following the completion of the sale, the vice president now directly owns 10,263 shares of the company's stock, valued at $333,547.50. The disclosure for this sale can be found here. Company insiders own 14.50% of the company's stock.

Hedge Funds Weigh In On Kewaunee Scientific

Several hedge funds have recently modified their holdings of KEQU. BlackRock Inc. increased its holdings in shares of Kewaunee Scientific by 58.2% during the second quarter. BlackRock Inc. now owns 13,102 shares of the technology company's stock valued at $198,000 after acquiring an additional 4,822 shares in the last quarter. Vanguard Group Inc. increased its holdings in shares of Kewaunee Scientific by 1.3% during the first quarter. Vanguard Group Inc. now owns 126,581 shares of the technology company's stock valued at $1,836,000 after acquiring an additional 1,683 shares in the last quarter. Minerva Advisors LLC increased its holdings in shares of Kewaunee Scientific by 0.9% during the third quarter. Minerva Advisors LLC now owns 174,432 shares of the technology company's stock valued at $2,843,000 after acquiring an additional 1,513 shares in the last quarter. Dimensional Fund Advisors LP increased its holdings in Kewaunee Scientific by 0.4% in the 3rd quarter. Dimensional Fund Advisors LP now owns 185,989 shares of the technology company's stock worth $3,273,000 after buying an additional 742 shares during the period. Finally, Renaissance Technologies LLC increased its holdings in Kewaunee Scientific by 0.7% in the 2nd quarter. Renaissance Technologies LLC now owns 98,111 shares of the technology company's stock worth $1,631,000 after buying an additional 700 shares during the period. Institutional investors and hedge funds own 32.69% of the company's stock.

Kewaunee Scientific Company Profile

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.